Pcv105 - Potential Reduction in Mortality and Hospitalisations With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure With Reduced Ejection Fraction in Ireland
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.650
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV